CDK4 and lung cancer: Further, we saw enhanced growth suppression in multiple breast and lung cancer cell lines treated with XAV and Palbociclib, demonstrating a consistent combinatorial effect of TNKS and CDK4 blockade across a broad spectrum of cancer cell lines of epithelial origins (S3D Fig).